Skip to content

Average Directional Index Review for Bioshares Biotechnology Product (BBP)

Currently, the 14-day ADX for Bioshares Biotechnology Product (BBP) is 21.29. Generally speaking, an ADX value from 0-25 would indicate an absent …

The 170 Shares of Biogen Inc. (BIIB) are sold by the Duff & Phelps Investment Management Co.

The fund owned 2,910 shares of the biotechnology company’s stock after selling 170 shares during the period. Duff & Phelps Investment Management …

The Galena Biopharma Inc. (GALE) Receives Buy Rating from Maxim Group

The brokerage currently has a $1.00 price objective on the biotechnology company’s stock. Several other brokerages also recently commented on …

ImmunoGen Inc. (IMGN) Receives $6.43 Average PT from Brokerages

Fisher Asset Management LLC now owns 253,701 shares of the biotechnology company’s stock valued at $751,000 after buying an additional 9,476 …

Cowen and Company Reaffirms Buy Rating for Heron Therapeutics Inc. (HRTX)

Cowen and Company currently has a $40.00 price objective on the biotechnology company’s stock. A number of other equities analysts also recently …

Innovative Young Biotechnologist Award

The Department of Biotechnology has invited applications for Innovative Young Biotechnologist Award (IYBA) to identify and nurture outstanding …

The BioCryst Pharmaceuticals Inc. to Post FY2016 Earnings of ($0.90) Per Share, Jefferies Group …

The biotechnology company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08.

The Heron Therapeutics Inc. (HRTX) Releases Quarterly Earnings Results, Misses Estimates By …

Heron Therapeutics Inc. (NASDAQ:HRTX) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.24) EPS for the …

The Ziopharm Oncology Inc. (ZIOP) Posts Quarterly Earnings Results, Hits Expectations

Ziopharm Oncology Inc. (NASDAQ:ZIOP) issued its earnings results on Wednesday. The biotechnology company reported ($0.11) earnings per share …

The Ligand Pharmaceuticals Inc. (LGND) Upgrade to Hold by The Zacks Investment Research

Ligand’s Captisol formulation technology has resulted in partnerships with … The biotechnology company reported $0.62 earnings per share for the …